tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Young Li, 2 are a BUY (25%), 6 are a HOLD (75%).
Analyst Young Li, currently employed at JEFFERIES, carries an average stock price target met ratio of 37.5% that have a potential upside of 5.53% achieved within 21 days.
Young Li’s has documented 16 price targets and ratings displayed on 4 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on RXST, Rxsight at 10-Jul-2025.
Analyst best performing recommendations are on CNMD (CONMED).
The best stock recommendation documented was for CNMD (CONMED) at 10/11/2022. The price target of $85 was fulfilled within 31 days with a profit of $10.04 (13.39%) receiving and performance score of 4.32.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 14-Aug-2023
$16
$6.48 (68.07%)
$16
2 days ago
(09-Jan-2026)
10/21 (47.62%)
$6.48 (68.07%)
110
Buy
Since 21-Jan-2020
$32
$22.48 (236.13%)
$61
2 years 5 months 2 days ago
(09-Aug-2023)
1/3 (33.33%)
$11.99 (59.92%)
73
Hold
$35
3 years 2 months 27 days ago
(14-Oct-2022)
0/2 (0%)
$8.78 (33.49%)
Hold
Since 16-Jul-2021
$46
$36.48 (383.19%)
$46
4 years 1 months 24 days ago
(18-Nov-2021)
0/2 (0%)
$5.44 (13.41%)
Buy
Since 23-Sep-2019
$65
$55.48 (582.77%)
$54
6 years 1 days ago
(10-Jan-2020)
5/6 (83.33%)
$15.2 (30.52%)
21
What Year was the first public recommendation made by Young Li?
